Active ingredients

DAPAVELDACTIN Plus 5/850 mg® :

• Film Coated Tablets

• Dapaveldactin plus® is a combination of dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and metformin, a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate.

Leaflet, registration license, and pack

Price: 38 L.E/ strip (7 tablets)

DAPAVELDACTIN Plus 5/1000 mg® :

• Film Coated Tablets

• Dapaveldactin plus® is a combination of dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and metformin, a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate.

Leaflet, registration license, and pack

Price: 38 L.E/ strip (7 tablets)

Indications

Dapaveldactin Plus is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:

• in patients inadequately controlled on their maximally tolerated dose of metformin alone.

• in combination with other glucose-lowering medicinal products, including insulin, in patients inadequately controlled with metformin and these medicinal products

• in patients already being treated with the combination of dapagliflozin and metformin as separate tablets.